| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $493K | -64.0% | -85.6% |
| R&D Expense | $3.0M | +53.6% | +74.8% |
| SG&A Expense | $1.3M | +6.7% | +18.1% |
| Operating Income | -$3.7M | -113.7% | -680.2% |
| Interest Expense | $3K | — | -21.0% |
| Net Income | -$3.7M | -115.1% | -663.5% |
| EPS (Basic) | -$1.29 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.7M | -24.3% | -59.7% |
| Current Assets | $2.9M | -44.6% | -67.8% |
| Total Assets | $3.2M | -43.0% | -66.1% |
| Current Liabilities | $2.3M | -8.3% | -17.7% |
| Total Liabilities | $2.3M | -8.3% | -17.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.3M | — | — |
| Capital Expenditures | $124K | — | — |
| Investing Cash Flow | -$124K | — | — |
| Financing Cash Flow | $4.6M | — | — |
| Free Cash Flow | -$6.4M | — | — |
| -1942.9% |
| EPS (Diluted) | -$1.29 | -63.3% | -1942.9% |
| $1.2M |
| -64.5% |
| -82.6% |